A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...
Digoxin is indicated in the management of certain supraventricular arrhythmias, particularly chronic atrial fibrillation and flutter, where its major beneficial effect is to reduce the ventricular ...
In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...
Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...
Digoxin is a medication used to help treat heart failure and heartbeat irregularities. Your digoxin levels tell you the amount of digoxin that is in your body at a certain time. Having too much or too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results